TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33475727

Group type: EXPERIMENTAL
Intervention: Essential Amino Acids (EAA) supplementation (n = 28)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Whey protein supplementation (n = 32)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (nutrition education, n = 32)
Number of subjects: 92
Study: 32886426

Group type: EXPERIMENTAL
Intervention: CPAP = 8 cmH2O
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: pH < 7.2
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: pCO2 > 70 mmHg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: FiO2 > 40%
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Chest retractions
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: More than two episodes of apnea requiring intervention
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Chest X-ray showing moderate–severe hyaline membrane disease (HMD)
Number of subjects: 118
Study: 35941669

Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin once daily for 28 days
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 32658020

Group type: EXPERIMENTAL
Intervention: Cancellous screw (CS) fixation with a 3-screw inverted triangle pattern
Number of subjects: 898

Group type: COMPARATOR
Intervention: Cancellous screw (CS) fixation with a 3-screw triangle formation
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Sliding hip screw (SHS) fixation
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Cancellous screw (CS) and sliding hip screw (SHS) technical factors
Number of subjects: 898
Study: 33361038

Group type: EXPERIMENTAL
Intervention: Specialized educational and psychological counseling (SEPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Current medical practice (Control)
Number of subjects: 60
Study: 32895226

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 1.5 mg bolus given every 10 min until NRS pain score <4
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intravenous bolus morphine 0.05 mg/kg body weight followed by 0.025 mg/kg/hour intravenous infusion
Number of subjects: 140
Study: 33400384

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy-based care program (RTCP)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control care program (CCP)
Number of subjects: 192
Study: 32948550

Group type: EXPERIMENTAL
Intervention: Sampling method (n=217)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Volunteering method (n=361)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Health status assessment
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Health needs assessment
Number of subjects: 578
Study: 35638971

Group type: EXPERIMENTAL
Intervention: Sprint interval exercise in normoxia (FIO2 = 0.209)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sprint interval exercise in hypoxia (FIO2 = 0.112)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Resting (control) in normoxia (FIO2 = 0.209)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Resting (control) in hypoxia (FIO2 = 0.112)
Number of subjects: 25
Study: 34770188

Group type: EXPERIMENTAL
Intervention: Community-based workshops utilizing a social norms-based mental health-integrated approach
Number of subjects: 148

Group type: COMPARATOR
Intervention: Poster campaigns addressing IPV
Number of subjects: 148
Study: 35942458

Group type: EXPERIMENTAL
Intervention: PDCA model education and training for midwives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional nursing mode
Number of subjects: 0
Study: 33761970

Group type: EXPERIMENTAL
Intervention: palbociclib alone
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: RB1 gene expression analysis on CTCs
Number of subjects: 46
Study: 32617881

Group type: EXPERIMENTAL
Intervention: hCG injection 36 hours before oocyte retrieval
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) injection 36 hours before oocyte retrieval
Number of subjects: 172

Group type: COMPARATOR
Intervention: No injection 36 hours before oocyte retrieval
Number of subjects: 172
Study: 33407689

Group type: EXPERIMENTAL
Intervention: Breastfeeding support program (90-min class, pamphlet, newsletter, email consultation)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Pamphlet intervention
Number of subjects: 141

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 141
Study: 33020080

Group type: EXPERIMENTAL
Intervention: Performance-based and self-Assessed measures of health literacy using the European Health Literacy Survey Questionnaire (HLS-EU-Q16) and the Newest Vital Sign (NVS).
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Combination of HLS-EU-Q16 and NVS measures.
Number of subjects: 212
Study: 34291988

Group type: EXPERIMENTAL
Intervention: 12.5% Δ9‐tetrahydrocannabinol (THC) cigarette
Number of subjects: 61
Study: 34063322

Group type: EXPERIMENTAL
Intervention: Taurisolo� (20 mg/Kg/die)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taurisolo� (400 mg twice daily for 8 weeks)
Number of subjects: 0
Study: 33728428

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 44
Study: 32424045

Group type: EXPERIMENTAL
Intervention: C-reactive protein point-of-care test (CRP-POCT) management strategy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: C-reactive protein point-of-care test (CRP-POCT)
Number of subjects: 40
Study: 35351531

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 2848
Study: 35924518

Group type: EXPERIMENTAL
Intervention: PI guidance group
Number of subjects: 65
Study: 32586139

Group type: EXPERIMENTAL
Intervention: Obese patients (BMI >30)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Non-obese patients (BMI ≤30)
Number of subjects: 301
Study: 35587723

Group type: EXPERIMENTAL
Intervention: 0.1% HA2k lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control lotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.1% HA2k solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 33934058

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (docetaxel, oxaliplatin, capecitabine; Arm A)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No induction chemotherapy (Arm B)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (Arm A)
Number of subjects: 55
Study: 35470085

Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 49
Study: 36163870

Group type: EXPERIMENTAL
Intervention: Fixed-duration pirtobrutinib plus venetoclax and rituximab
Number of subjects: 600

Group type: COMPARATOR
Intervention: Venetoclax and rituximab
Number of subjects: 600
Study: 33549474

Group type: EXPERIMENTAL
Intervention: MiSight® 1 day (omaifilcon A, CooperVision, Inc.)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Proclear® 1 day (omaifilcon A, CooperVision, Inc.)
Number of subjects: 144
Study: 32735021

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 30
Study: 34362624

Group type: EXPERIMENTAL
Intervention: POC‐PEOF
Number of subjects: 126

Group type: COMPARATOR
Intervention: FAST
Number of subjects: 126
Study: 34016350

Group type: EXPERIMENTAL
Intervention: N-acetyl-l-cysteine (NAC) 1000 mg/kg in basal diet
Number of subjects: 120

Group type: COMPARATOR
Intervention: Basal diet
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Basal diet with NAC
Number of subjects: 120
Study: 34116813

Group type: EXPERIMENTAL
Intervention: Group treatment
Number of subjects: 42
Study: 32160043

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 30
Study: 34674405

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) with a composition of 60% fat, 30% protein, and 10% fiber for 8 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Correlation between serum adiponectin and serum IGF-1 levels
Number of subjects: 14
Study: 33973718

Group type: EXPERIMENTAL
Intervention: Community of inquiry‐based blended learning
Number of subjects: 233

Group type: COMPARATOR
Intervention: Face‐to‐face teaching (Control)
Number of subjects: 233
Study: 32048384

Group type: EXPERIMENTAL
Intervention: Personal consumption of hypnotic drugs
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Personal consumption of anxiolytics
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Personal drug consumption
Number of subjects: 249

Group type: COMPARATOR
Intervention: Insomnia status
Number of subjects: 249
Study: 33827450

Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation program
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care and physical activity recommendation
Number of subjects: 340
Study: 32799403

Group type: EXPERIMENTAL
Intervention: Clinical screening
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Echocardiography screening
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Definitive echocardiography
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Borderline RHD
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Definite RHD
Number of subjects: 417
Study: 35898170

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 34432008

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen-progestin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens alone or combined with estrogen-progestin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal routes of HT administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment with natural progesterone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of HT
Number of subjects: 0
Study: 32055041

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg intravenous)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35747897

Group type: EXPERIMENTAL
Intervention: Zinc supplementation for 4 months
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 33857237

Group type: EXPERIMENTAL
Intervention: Self-reported acne (CDLQI)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Self-reported acne (CADI)
Number of subjects: 249
Study: 33589311

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (Group 1) - home-based dietary plan, counselling by a dietitian.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (Group 2) - advised to take a liquid diet of their own choice, including shakes, juices, and milk, along with protein supplements.
Number of subjects: 50
Study: 32102557

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT) using pre-induction chemotherapy (IC) images (Group A)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT) using post-induction chemotherapy (IC) images (Group B)
Number of subjects: 212
Study: 35616226

Group type: EXPERIMENTAL
Intervention: Labels 'episode of back pain', 'lumbar sprain', 'non-specific LBP'
Number of subjects: 1375

Group type: COMPARATOR
Intervention: Labels 'disc bulge', 'degeneration', 'arthritis'
Number of subjects: 1375

Group type: EXPERIMENTAL
Intervention: All labels
Number of subjects: 1375
Study: 33505717

Group type: EXPERIMENTAL
Intervention: Activity Tracking Intervention (ATI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study: 32614141

Group type: EXPERIMENTAL
Intervention: Liquid chromatography/mass spectrometry (LC-MS) with stable-isotope labeled peptides for detection and quantitation of PSA variant in urine
Number of subjects: 53
Study: 36410799

Group type: EXPERIMENTAL
Intervention: Active transdermal glyceryl trinitrate
Number of subjects: 1149

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 1149
Study: 33972367

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 2193

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2193
Study: 35929990

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C (1.5 g/kg/d, intravenously for 3 hours from D1 to D3) plus FOLFOX +/- bevacizumab
Number of subjects: 442

Group type: COMPARATOR
Intervention: FOLFOX +/- bevacizumab
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C plus FOLFOX +/- bevacizumab
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C plus chemotherapy
Number of subjects: 442

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 442
Study: 34857535

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33825412

Group type: EXPERIMENTAL
Intervention: Integrated Traditional Chinese and Western Medicine (IM)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Western medicine (WM)
Number of subjects: 300
Study: 35105443

Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control (placebo procedure)
Number of subjects: 220
Study: 34034274

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 130
Study: 36336005

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 1115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1115
Study: 33398361

Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKAs)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nonvitamin K oral anticoagulants (NOACs)
Number of subjects: 23
Study: 34051588

Group type: EXPERIMENTAL
Intervention: Virtual simulation-based mobile learning app
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional paper materials
Number of subjects: 100
Study: 32384418

Group type: EXPERIMENTAL
Intervention: Kane formula
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: EVO 2.0
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Haigis
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Holladay 2
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Olsen
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Holladay 1
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Hill‐RBF 2.0
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: SRK/T
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Barrett Universal II
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Hoffer Q
Number of subjects: 182
Study: 34043064

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 0.5 mg/kg before anesthesia induction
Number of subjects: 85

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 85
Study: 34097062

Group type: EXPERIMENTAL
Intervention: EQW/DAPA (2 mg weekly/10 mg daily)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: PHEN/TPM (7.5 mg/46 mg ER daily)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: EQW (2 mg weekly)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: DAPA (10 mg daily)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: DAPA/MET (10 mg/2000 mg XR daily)
Number of subjects: 119
Study: 33497408

Group type: COMPARATOR
Intervention: Pain treatment groups
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Postoperative pain level at POD 4
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Type of surgery
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Female gender and having a paid job
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Long term fear of surgery
Number of subjects: 200
Study: 32507434

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Placebo Acupressure
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (Routine cares)
Number of subjects: 57
Study: 35750094

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 32650683

Group type: EXPERIMENTAL
Intervention: ATG (4.5 mg/kg thymoglobulin plus cyclosporine [CsA], methotrexate [MTX], and mycophenolate mofetil [MMF])
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control (CsA, MTX, and MMF)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control
Number of subjects: 263
Study: 35314257

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg or 25 mg)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 32287075

Group type: EXPERIMENTAL
Intervention: New PD diagnosis
Number of subjects: 8722
Study: 35139937

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no platelet-rich plasma gel)
Number of subjects: 40
Study: 34967125

Group type: EXPERIMENTAL
Intervention: Whitening toothpastes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control ligatures (not specified toothpaste)
Number of subjects: 40
Study: 33030582

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (250 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no magnesium supplementation)
Number of subjects: 101
Study: 35914643

Group type: EXPERIMENTAL
Intervention: Thought Suppression
Number of subjects: 139

Group type: COMPARATOR
Intervention: Focused Distraction
Number of subjects: 139
Study: 33334128

Group type: EXPERIMENTAL
Intervention: Pedicled left internal thoracic artery graft
Number of subjects: 109

Group type: COMPARATOR
Intervention: Skeletonized left internal thoracic artery graft
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 109
Study: 32293362

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (CROSS regimen): paclitaxel 50 mg/m2; carboplatin (AUC = 2), q1w, 5 cycles; concurrent radiotherapy, 41.4 Gy/23 F, over 5 weeks
Number of subjects: 456

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy: paclitaxel 175 mg/m2; cisplatin 75 mg/m2, q21d, 2 cycles
Number of subjects: 456
Study: 36147247

Group type: EXPERIMENTAL
Intervention: Conditional economic incentives and motivational interviewing
Number of subjects: 246

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 246
Study: 32054537

Group type: EXPERIMENTAL
Intervention: Tai Chi (2 sessions of 60 minutes per week for 8 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 80
Study: 35343294

Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Bidirectional violence
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Coping subscales, social support, and stigma
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patient adherence to medication and care
Number of subjects: 180
Study: 33309478

Group type: EXPERIMENTAL
Intervention: Mindfetalness method
Number of subjects: 144
Study: 35975806

Group type: EXPERIMENTAL
Intervention: Participatory ergonomic intervention
Number of subjects: 116
Study: 33239219

Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (CHO group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Flavored water (placebo group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Fasting group
Number of subjects: 75
Study: 32520820

Group type: EXPERIMENTAL
Intervention: Hybrid treatment
Number of subjects: 115

Group type: COMPARATOR
Intervention: Guided internet-delivered pain management treatment
Number of subjects: 115
Study: 34775065

Group type: EXPERIMENTAL
Intervention: Protocol 1 (irradiation device in contact with the skin)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Protocol 2 (device 3 cm away from the skin)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Protocol 2
Number of subjects: 41
Study: 34949169

Group type: EXPERIMENTAL
Intervention: integrated care + fotonovela
Number of subjects: 150

Group type: COMPARATOR
Intervention: integrated care + standard education
Number of subjects: 150
Study: 34240642

Group type: EXPERIMENTAL
Intervention: Progressive resistance strength program for hand muscles over 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (single education session)
Number of subjects: 60
Study: 36167548

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33772757

Group type: EXPERIMENTAL
Intervention: One year of antiseizure medication (ASM) therapy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Three years of antiseizure medication (ASM) therapy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Active epilepsy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Duration of initial ASM treatment
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Prognostic model score
Number of subjects: 149
Study: 32544121

Group type: EXPERIMENTAL
Intervention: Modeled-WALANT state (after 10 mL of 1% lidocaine injection)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline driving (preoperative drive)
Number of subjects: 12
Study: 35587504

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 minutes over 10 sessions across 2 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 30
Study: 33436117

Group type: EXPERIMENTAL
Intervention: Intervention studies in 1998
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Intervention studies in 2018
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Reviews in 2018
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Reviews in 1998
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Randomised trials in 2018
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Randomised trials in 1998
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: T2-T4 research in 2018
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: T2-T4 research in 1998
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: T3/T4 research
Number of subjects: 2046
Study: 35352668

Group type: EXPERIMENTAL
Intervention: Peri-urethral injection of autologous mucosa stem cells
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mini-sling insertion
Number of subjects: 30